ABVC · Abvc Biopharma, Inc. · Documents
$0.93
+0.02 (+2.20%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2026, the Company reported net loss of $2,500,418. As of June 30, 2026, the Company's working capital deficit was $5,282,776. In addition, the Company had net cash outflows of $1,138,656 from operating activities for the six months ended June 30, 2026. These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$25.59M
Shares
26.65M
Volume · Oct 20
11.82K
Avg daily vol (3M)
104.5K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | — | 2026-09-29 | 2026-10-28 | |
| 8-K | — | 2026-08-27 | — | |
| 8-K/A | — | 2026-08-12 | 2026-08-03 | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-08-04 | 2026-08-03 | |
| PRE 14A | — | 2026-07-28 | — | |
| 8-K | — | 2026-07-02 | — | |
| 10-Q | — | 2026-05-18 | 2026-03-31 | |
| NT 10-Q | — | 2026-05-15 | 2026-03-31 | |
| 8-K | — | 2026-03-27 | — | |
| DEF 14A | — | 2026-03-05 | 2026-03-26 | |
| 10-K | — | 2026-03-03 | 2025-12-31 | |
| 10-Q/A | — | 2026-03-03 | 2025-09-30 | |
| 8-K | — | 2026-03-03 | — | |
| PRE 14A | — | 2026-02-05 | — | |
| 8-K/A | — | 2026-01-16 | 2025-04-30 | |
| 10-Q | — | 2025-11-03 | 2025-09-30 | |
| 8-K | — | 2025-11-03 | — | |
| 8-K | — | 2025-10-30 | 2025-10-28 | |
| 8-K/A | — | 2025-09-12 | 2024-10-18 | |
| 8-K | — | 2025-08-14 | — | |
| 10-Q | — | 2025-08-13 | 2025-06-30 | |
| 8-K/A | — | 2025-07-18 | 2024-02-08 | |
| 8-K | — | 2025-06-04 | 2025-06-03 | |
| 8-K/A | — | 2025-05-30 | 2025-04-30 | |
| S-3 | — | 2025-05-22 | — | |
| DEF 14A | — | 2025-05-16 | 2025-06-03 | |
| 8-K/A | — | 2025-05-14 | 2024-07-12 | |
| 8-K/A | — | 2025-05-14 | 2025-04-30 | |
| 8-K/A | — | 2025-05-06 | 2025-04-30 | |
| 8-K/A | — | 2025-05-02 | 2025-04-15 | |
| 8-K | — | 2025-05-01 | — | |
| 10-Q | — | 2025-04-30 | 2025-03-31 | |
| 8-K | — | 2025-04-30 | — | |
| PRE 14A | — | 2025-04-25 | 2025-04-24 | |
| 8-K/A | — | 2025-04-16 | 2025-04-15 | |
| 8-K | — | 2025-04-15 | — | |
| 10-K | — | 2025-04-15 | 2024-12-31 | |
| NT 10-K | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-03-07 | 2025-03-05 | |
| 8-K/A | — | 2025-01-13 | 2024-07-12 | |
| 8-K | — | 2025-01-06 | — | |
| 8-K | — | 2024-11-14 | — | |
| 10-Q | — | 2024-11-14 | 2024-09-30 | |
| 8-K | — | 2024-11-04 | — | |
| 8-K | — | 2024-10-18 | — | |
| 8-K | — | 2024-09-10 | — | |
| 8-K | — | 2024-08-20 | — | |
| 8-K | — | 2024-08-15 | — | |
| 10-Q | — | 2024-08-14 | 2024-06-30 |
Showing 1–50 of 181 filings